Mark Lemmon, PhD, FRS, David A. Sackler Professor of Pharmacology, Associate Cancer Center Director for Basic Science at Yale Cancer Center, and Co-director of the Cancer Biology Institute, has recently been named Chair of the Editorial Board for the Biochemical Journal. The Biochemical Journal is a leading bioscience journal publishing high-impact scientific research papers and reviews on the latest advances and new mechanistic concepts in the fields of biochemistry, cellular biosciences, and molecular biology. It is published by Portland Press, the publishing arm of The Biochemical Society, and was established in 1906.
Dr. Lemmon joined Yale in 2015 from the University of Pennsylvania’s Perelman School of Medicine to lead the Cancer Biology Institute on Yale West Campus. His research focuses on the signaling pathways of receptor tyrosine kinases (RTKs), which, when mutated, cause cancers and other diseases. Dr. Lemmon looks forward to leading the Editorial Board of the Biochemical Journal, which is comprised of leaders in the field from across the globe, and to contributing to the long and distinguished history of the Journal to promote a broad range of cutting-edge research in modern biochemistry and systems biology.